Home Immutep

Immutep

Actualité internationale

World News – CA – Immutep shares rise 190% on positive results in breast cancer treatment studies

. . Shares of Immumetp Ltd. . undefined, an Australian biotechnology listed on Nasdaq, rose 190% Thursday after the company posted positive results...

Actualité internationale

World News – US – Immutep shares up 57% thanks to two big announcements

. . Small-cap immunotherapy company Immutep Ltd (ASX: IMM) is absolutely flying today. The Immutep share price is 57% higher. 14% at the...

Actualité internationale

World News – United States – US Futures Fall as Pulse Lock-out Fades

. . U.S. stock futures fell Thursday as U.S. lawmakers appeared to be far from reaching consensus on the terms of the next...

Actualité internationale

World News – CA – Immutep’s (ASX: IMM) breast cancer therapy for Phase 2 trial in China – The Market Herald

. . Immutep's Chinese partner (IMM), EOC Pharma, will start a phase II clinical trial in patients with metastatic breast cancer.

Actualité internationale

World News – USA – Immutep’s Chinese partner launches Phase II clinical trial in patients with metastatic breast cancer

. . Global biotechnology company Immutep (ASX: IMM) has announced that its Chinese partner EOC Pharma will start a phase II clinical trial...

Actualité internationale

World News – USA – Closing Bell: Today’s Biggest Small Cap Movers on ASX – Stockhead

. . Closing Bell is Stockhead's daily round-up of the ASX's biggest players - winners and losers alike. The data is collected after...

Actualité internationale

World News – CA – Immutep Updates AIPAC Breast Cancer Study and Announces a New Study

. . Immunotherapy company Immutep (ASX: IMM) announced what it describes as promising overall survival data from a breast cancer study with its...

Actualité internationale

World News – CA – ASX Stock of the Day: Immutep (ASX: IMM) Shares Up 60% On Test News

Immutep Ltd (ASX: IMM) share price is up nearly 60% today following some encouraging results from the biopharmaceutical company's clinical trials